tiprankstipranks
Trending News
More News >
Island Pharmaceuticals Ltd (AU:ILA)
ASX:ILA
Australian Market

Island Pharmaceuticals Ltd (ILA) Ratios

Compare
19 Followers

Island Pharmaceuticals Ltd Ratios

AU:ILA's free cash flow for Q2 2026 was AU$0.00. For the 2026 fiscal year, AU:ILA's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
8.40 22.27 2.45 7.77 8.44
Quick Ratio
8.40 22.27 2.45 7.77 8.44
Cash Ratio
7.99 21.56 1.59 7.57 8.24
Solvency Ratio
-5.46 0.10 -2.70 0.25 0.35
Operating Cash Flow Ratio
-4.27 -8.23 -3.03 -10.27 -3.23
Short-Term Operating Cash Flow Coverage
0.00 0.00 -7.50 0.00 0.00
Net Current Asset Value
AU$ 6.37MAU$ 7.16MAU$ 1.52MAU$ 1.79MAU$ 4.32M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.16 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.28 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.22 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.12 1.05 1.69 1.15 1.13
Debt Service Coverage Ratio
0.00 0.00 -3.35 -313.49 0.00
Interest Coverage Ratio
0.00 -196.28 -111.17 -323.13 0.00
Debt to Market Cap
0.00 0.00 0.06 0.00 0.00
Interest Debt Per Share
0.00 <0.01 <0.01 <0.01 0.00
Net Debt to EBITDA
1.40 0.00 0.44 0.71 1.84
Profitability Margins
Gross Profit Margin
-3306.08%-1081.42%-80.78%100.00%0.00%
EBIT Margin
-33552.51%-3326.06%-228.81%-25498.86%0.00%
EBITDA Margin
-22221.41%0.00%-225.17%-25498.83%0.00%
Operating Profit Margin
-36720.03%-4507.49%-410.39%-26282.24%0.00%
Pretax Profit Margin
-32802.41%-3296.73%-228.86%-25580.20%0.00%
Net Profit Margin
-32617.60%-3296.73%-228.86%-25580.20%0.00%
Continuous Operations Profit Margin
-32562.91%-3296.73%-228.86%-25580.20%0.00%
Net Income Per EBT
99.44%100.00%100.00%100.00%100.00%
EBT Per EBIT
89.33%73.14%55.77%97.33%92.80%
Return on Assets (ROA)
-89.78%-52.32%-111.69%-138.12%-53.21%
Return on Equity (ROE)
-100.58%-54.78%-188.59%-158.54%-60.37%
Return on Capital Employed (ROCE)
-113.22%-74.89%-338.17%-162.89%-65.05%
Return on Invested Capital (ROIC)
-112.40%-74.89%-149.01%-162.89%-65.05%
Return on Tangible Assets
-99.58%-52.32%-111.69%-138.12%-53.21%
Earnings Yield
-8.12%-16.15%-41.20%-36.66%-22.12%
Efficiency Ratios
Receivables Turnover
0.11 0.66 1.41 0.64 0.00
Payables Turnover
3.57 9.34 7.26 10.14 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
<0.01 0.02 0.49 <0.01 0.00
Working Capital Turnover Ratio
<0.01 0.03 0.76 <0.01 0.00
Cash Conversion Cycle
3.08K 512.24 209.45 532.40 0.00
Days of Sales Outstanding
3.18K 551.32 259.75 568.40 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
102.11 39.08 50.30 36.00 0.00
Operating Cycle
3.18K 551.32 259.75 568.40 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.01 -0.02 -0.04 -0.03 -0.02
Free Cash Flow Per Share
-0.01 -0.02 -0.04 -0.03 -0.02
CapEx Per Share
<0.01 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-1.84M -553.67K 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
-1.84M -553.67K 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 0.00 -7.50 0.00 0.00
Operating Cash Flow to Sales Ratio
-166.53 -23.28 -2.53 -244.80 0.00
Free Cash Flow Yield
-4.20%-11.41%-45.52%-35.09%-15.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-12.66 -6.19 -2.43 -2.73 -4.52
Price-to-Sales (P/S) Ratio
4.08K 204.10 5.56 697.74 0.00
Price-to-Book (P/B) Ratio
12.74 3.39 4.58 4.32 2.73
Price-to-Free Cash Flow (P/FCF) Ratio
-24.50 -8.77 -2.20 -2.85 -6.28
Price-to-Operating Cash Flow Ratio
-24.81 -8.77 -2.20 -2.85 -6.28
Price-to-Earnings Growth (PEG) Ratio
0.34 0.22 1.31 -0.33 -0.20
Price-to-Fair Value
12.74 3.39 4.58 4.32 2.73
Enterprise Value Multiple
-16.96 0.00 -2.03 -2.03 -2.68
Enterprise Value
80.65M 17.02M 5.71M 5.72M 7.00M
EV to EBITDA
-16.45 0.00 -2.03 -2.03 -2.68
EV to Sales
3.65K 143.11 4.57 517.15 0.00
EV to Free Cash Flow
-21.95 -6.15 -1.81 -2.11 -3.73
EV to Operating Cash Flow
-21.95 -6.15 -1.81 -2.11 -3.73
Tangible Book Value Per Share
0.03 0.04 0.02 0.02 0.05
Shareholders’ Equity Per Share
0.03 0.04 0.02 0.02 0.05
Tax and Other Ratios
Effective Tax Rate
<0.01 0.00 0.44 0.00 0.00
Revenue Per Share
<0.01 <0.01 0.01 <0.01 0.00
Net Income Per Share
-0.03 -0.02 -0.03 -0.03 -0.03
Tax Burden
0.99 1.00 1.00 1.00 1.00
Interest Burden
0.98 0.99 1.00 1.00 1.00
Research & Development to Revenue
92.83 11.81 1.82 103.09 0.00
SG&A to Revenue
58.08 16.60 1.15 145.03 0.00
Stock-Based Compensation to Revenue
12.68 2.83 0.00 26.90 0.00
Income Quality
0.51 0.71 1.10 0.96 0.72
Currency in AUD